Moderna receives FDA approval for Phase 2 COVID-19 vaccine trial

Yahoo Finance’s Brian Sozzi and Alexis Christoforous break down the market action for Moderna, after the company announced it received FDA clearance for its coronavirus vaccine for phase 2 trial.